# Trade Mark Journal No.2025/029 18 July 2025

## WO0000001861715 (5)

Office of origin: United States of America

Date of International Registration:5 May 2025
Date of designation in the UK: 5 May 2025

The mark consists of an abstract design comprised of an orange curved line in between two blue curved lines.

The mark contains the colours blue and orange.

Curved lines.

International priority date claimed: 18 December 2024 (United States of America) (98910486)

Class 5
  Pharmaceutical preparations and substances for the treatment of neurological, neuropsychiatric, neurodegenerative, viral, metabolic, obesity, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, osteogenesis, immune system, central nervous system, peripheral nervous system, and voluntary muscle movement related diseases and disorders.

Biohaven Therapeutics Ltd.

Representative: Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C., 1101 K Street N.W., Washington DC 20005, UNITED STATES OF AMERICA